tbuckley/cabot-search huggingface dataset:
Deaths
Journal: JAMA (1974)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PLoS Medicine Issue Image | Vol. 2(9) September 2005
Journal: PLoS Medicine (2005)

Vivien Ressler was born in Havana, Cuba, and, in 1961, moved to Caracas, Venezuela, where she was raised along with a brother and two sisters. In 1978, she moved to New York city, and in 1989, she moved, with her husband and family, to San Diego, California, where she established an independent studio. She works with mixed media, watercolor, and acrylics. Her work has always been influenced by the strong colors of the Caribbean, where she grew up. Vivien holds an Associate Degree in Interior Design from the Escuela Villasmil de Leon, in Caracas, Venezuela, and a Bachelor of Arts from Hunter College in New York, where she completed a dual major in Education and Fine Arts. She has studied at the Art Students League and the National Academy School of Fine Arts in New York, as well as numerous workshops with artists throughout the United States. Her work can be found in collections both in the United States and abroad. Image Credit: Vivien Ressler (http://www.vivienressler.com)
Reye's syndrome and aspirin. Evidence for a dose-response effect
Authors: P. F. Pinsky
Journal: JAMA (1988)

Data collected from the Public Health Service Main Study of Reye's Syndrome and Medications were analyzed to assess the relationship between the development of Reye's syndrome and the dose of aspirin received during the antecedent respiratory or chickenpox illness. Among those exposed to aspirin, case-patients were found to have received greater average daily and maximum daily doses of aspirin and greater doses of aspirin on the first four days of the antecedent illness (median, 25.1 mg/kg; 33.0 mg/kg; and 65.4 mg/kg; respectively) than did controls (median, 14.5 mg/kg; 19.0 mg/kg; and 27.0 mg/kg; respectively). The excess risk associated with increasing aspirin doses was due primarily to intermediate levels of dose (eg, 15 to 27 mg/kg per day) rather than higher levels (&gt;27 mg/kg per day). The dose difference between exposed case-patients and controls was greatest on days 3 and 4 of the antecedent illness. (<i>JAMA</i>1988;260:657-661)
Medizinische Klinik, Munich
Journal: JAMA (1965)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Commentary
Authors: Sachin Wani
Journal: Endoscopy (2020)

In this case series, Trindade and colleagues elegantly describe the use of hybrid argon plasma coagulation (APC) in the management of five patients with refractory Barrett’s esophagus (BE)-related neoplasia. Although the end point of complete eradication of intestinal metaplasia (CE-IM) is achieved in 2 – 3 sessions of endoscopic eradication therapy in a substantial proportion of BE-related neoplasia patients, a small fraction of patients are diagnosed with refractory BE. This is often defined as inability to achieve CEIM in 5 – 6 sessions, with incomplete response defined as failure to achieve CEIM in 3 sessions. However, standardization of the definition of refractory BE is of critical importance. Risk factors for refractory BE include lack of long-term reflux control, hiatal hernia, and BE segment length > 5 cm.
Migraine
Authors: Joel R. Saper
Journal: JAMA (1978)

THE MOST useful therapeutic tool in the treatment of a patient with chronic headache is the establishment of a trusting relationship between physician and patient. The physician must convey a genuine interest in the patient's distress, giving the patient ample time to discuss his symptoms and the social and emotional disruptions that either promote the symptoms or arise as a result of them. Because the headache sufferer is often anxious and frightened, a full explanation of the diagnostic and treatment approach can help allay inappropriate fear. Unfounded or premature emphasis on emotional factors as a cause of the headaches must be avoided, lest it encourage a defensive posture toward the physician and prevent the development of the confidence necessary for successful treatment. <h3>NONMEDICAL TREATMENT</h3><h3>Isolating Triggering Factors</h3> Migraine can be viewed as a genetically determined physiologic predisposition that is influenced by a wide variety of emotional, biological, and constitutional factors,
Lovastatin efficacy in reducing low-density lipoprotein cholesterol levels on high- vs low-fat diets
Authors: M. M. Cobb
Journal: JAMA (1991)

The effectiveness of lovastatin was compared with both a high-fat vs low-fat diet. Hypercholesterolemic subjects were studied under metabolic ward conditions for diet periods of 3 weeks while receiving lovastatin (40 mg/d) or placebo. Multiple lipoprotein levels were measured during the final week of each diet period. Nineteen subjects completed the study on the high-fat (43% of kilojoules) diet and 16 on the low-fat (25% of kilojoules) diet. Lovastatin reduced total cholesterol by 23% and low-density lipoprotein cholesterol by 30%, compared with placebo on both diets, with no significant diet-drug interaction. High-density lipoprotein cholesterol was raised by 7% to 8% on the diet regimens. Addition of lovastatin to the low-fat diet permitted 80% of subjects on this diet, but less than 50% of those on the high-fat diet, to achieve current guidelines. Although lovastatin produces a comparable percentage reduction in lipoprotein profiles on either diet, the accompanying low-fat diet remains advisable for additional reduction of low-density lipoprotein cholesterol levels to specified goals. (<i>JAMA</i>. 1991;265:997-1001)
MICHIGAN STATE BOARD OF HEALTH.
Authors: Henry B Baker
Journal: JAMA (1883)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Lectures on the Anatomy of the Intestinal Canal and Peritoneum in Man
Authors: F. Treves
Journal: BMJ (1885)

MR. PRESIDENT AND GENTLEMEN,-The account of the intestinal canal and peritoneum in man, that I have the honour to bring before you, is derived from the systematic examination of one hundred fresh bodies.Through the kindness of my colleagues, Drs.Sutton and Turner, the pathologists to the London Hospital, I was enabled to open, before the performance of the usual necropsy, all the bodies of patients that had died of other than abdominal disease.The bodies, therefore, were quite fresh, and, in many instances, still warm.I had long been convinced that a study of this part of anatomy was rendered liable to many fallacies when conducted in dissecting-room subjects in whom decomposition had advanced, and in.whom one could expect, for various reasons, some displacement of parts.Certain questions as to vascular-npply I have-followeAl out in in- jected -preparations.I have also derivdd considerable information frorm the dissection of a number of fcetuses of various ages.Moreover, through the kindness and coutte6yof-Mr.Beddard, the Prosectot to the Zoological Society, I have been enabled*o make a de-
10 Minute consultation - Snoring
Authors: Robert J Parker, Maxine Hardinge, Clare Jeffries
Journal: BMJ (2005)

An overweight, 49 year old male smoker attends your surgery with his wife. His snoring, which has been a running joke in the family, has become worse in the last six months, and his wife now sleeps in a separate room. When the couple stayed in a hotel recently his noise was remarked on by other guests. They want to know what they can do.
Abstract 2151: Long-Term Outcome in Patients Treated with Sirolimus Eluting Stents in Complex Coronary Artery Lesions. Analysis of 3-year Results of the Randomized SCANDSTENT Trial
Authors: Henning Kelbćk, Leif Thuesen, Skejby Sygehus, Lene Kløvgaard, Steffen Helqvist, Lars R Krussel, Skejby Sygehus, Kari Saunamäki, Jens F Lassen, Skejby Sygehus, Erik Jørgensen
Journal: Circulation (2007)

Background - The long-term outcome of patients with complex coronary artery lesions treated with drug-eluting stents is unknown. This study evaluated the 3-year clinical outcome of patients randomized in the SCANDSTENT study to have sirolimus-eluting stents (SES) or bare metal stents (BMS) implanted in their complex lesions. Methods and Results - We randomly assigned 322 patients with symptomatic coronary artery disease and either a total coronary occlusion, a lesion located in a bifurcation, in an ostial or in an angulated segment of the coronary artery to have SES or BMS implanted. At 3 years, major adverse cardiac events had occurred in 24 patients (15%) in the SES group and in 59 patients (37%) in the BMS group ( P &lt;0.001). Four versus 2 patients suffered a cardiac death (NS), and 5 versus 1 died of a non-cardiac disease (NS). Six patients in the SES group versus 15 patients in the BMS group suffered a myocardial infarction ( P &lt;0.05), and target lesion revascularization was performed in 8 patients (4.9%) versus 53 patients (33.8%), respectively ( P &lt;0.001); of these 4 in the SES versus 7 in the BMS group was performed between 1 and 3 years after the index treatment (NS). According to revised definitions, stent thrombosis occurred in 5 patients (3.1%) in the SES group and in 7 patients (4.4%) in the BMS group (NS); very late stent thromboses were observed in 4 versus 1 patient. Conclusions - A continued benefit was observed out to 3 years after implantation of SES in patients with complex coronary artery lesions. Late adverse events occurred less frequently in the SES group, and stent thromboses occurred rarely after 1 year.
Handbuch der normalen und pathologischen Physiologie, mit Berüucksichtigung der experimentellen Pharmakologie.
Journal: JAMA (1927)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Medical News
Journal: JAMA (1930)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Extensively Drug-Resistant Tuberculosis—United States, 1993-2006
Journal: JAMA (2007)

The worldwide emergence of extensively drug-resistant tuberculosis (XDR TB) and a provisional definition for this form of TB were first reported in November 2005. A more detailed description of these findings and preliminary data from the U.S. National TB Surveillance System (NTSS) were published in 2006. The U.S. data indicated that 74 TB cases reported during 1993-2004 met the case definition for XDR TB. Subsequent reports suggested different definitions for XDR TB. In October 2006, the World Health Organization convened an Emergency Global Task Force on XDR TB, which revised the case definition to specify resistance to at least isoniazid and rifampin among first-line anti-TB drugs, resistance to any fluoroquinolone, and resistance to at least one second-line injectable drug (amikacin, capreomycin, or kanamycin). This report updates the 2006 report on XDR TB in the United States, using the revised case definition and provisional data for 2006. NTSS data were analyzed for reported XDR-TB cases during 1993-2006; a total of 49 cases (3% of evaluable multidrug-resistant [MDR] TB cases) met the revised case definition for XDR TB. Of these, 17 (35%) were reported during 2000-2006. Compared with 1993-1999, cases from 2000-2006 were more likely to be in persons who were foreign born and less likely to be in persons with human immunodeficiency virus (HIV) infection. XDR TB presents a global threat and a challenge to TB-control activities in the United States. To prevent the spread of XDR TB, renewed vigilance is needed through drug-susceptibility testing, case reporting, specialized care, infection control, and expanded capacity for outbreak detection and response.
Medical and surgical aspects of hiatus hernia
Authors: B. Shatz
Journal: JAMA (1970)

Dr. Bernard Sunshine, First-Year Resident in Surgery, the Jewish Hospital of St. Louis, and Assistant in Surgery, Washington University School of Medicine: A 38-year-old white businessman was admitted to Jewish Hospital on Dec 10, 1968, with a chief complaint of indigestion beginning when he was a teenager. At that time, he began to notice pain following the ingestion of spicy foods or large meals. The pain was characterized as mild, nonradiating, and epigastric in location. It was associated with eructation and flatulence lasting 15 to 30 minutes and subsiding spontaneously. Antacids brought significant relief. During the five years prior to admission, the symptoms increased in intensity and frequency. They were exacerbated by lying supine and were only mildly relieved by standing or lying with the head of the bed elevated. For two years prior to admission, the patient complained of difficulty with swallowing, stating that the food would "get stuck"
Toxic effects of toluene
Authors: C. M. Fischman
Journal: JAMA (1979)

<h3>To the Editor.—</h3> The letter by Flewellen and Bee (241:884, 1979) provides a useful tool for the rapid determination of the ponderal index. Certainly, their efforts to encourage the medical community to adopt a standard method for quantifying obesity deserve support. Cube root tables are not usually readily available to the clinician, as the authors point out, but electronic calculators, which can do cube roots, are becoming relatively commonplace. I want to identify a point of possible confusion for those who wish to calculate the ponderal index. To obtain ponderal indices in the range of 7 to 14, the height, in<i>inches</i>, and the weight, in<i>pounds</i>, must be used in the formula. Substantially different values are obtained if calculations are performed using centimeters and kilograms.
Don't be rigid about flexible sigmoidoscopy
Authors: L. Taylor
Journal: JAMA (1987)

<h3>To the Editor.—</h3> Numerous studies<sup>1-7</sup>have compared rigid sigmoidoscopy with flexible lower gastrointestinal endoscopy, and in most the flexible endoscopic procedure has been shown to be superior because of the greater length of bowel examined, the greater yield of pathological lesions, decreased patient discomfort, and wider physician and patient acceptance. All reports emphasize the number of lesions missed by the rigid sigmoidoscope because of its limited length and all presume that the alternative—flexible endoscopy—is as efficacious as rigid sigmoidoscopy in detecting distal lesions. We are aware of only one report<sup>8</sup>comparing the two modalities in which a lesion that was seen with the rigid sigmoidoscope was not seen during examination by flexible sigmoidoscopy. We recently encountered two patients with synchronous colonic cancers in which one of the lesions was not detected during examination by flexible sigmoidoscopy, which was performed by an experienced endoscopist. In the first case, the
Cyclooxygenase 2 Selective Agents and Upper Gastrointestinal Disease
Authors: H. Fernandez
Journal: JAMA (2000)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
SUPERCOOLED SURGERY
Journal: JAMA (1965)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
CLINICAL MEMORANDA.
Authors: ARTHUR R. EDWARDS
Journal: JAMA (1896)

<h3>I. CASE OF CIRRHOSIS OF LIVER WITH PRE-ASCITIC EDEMA OF LOWER EXTREMITIES.</h3> J. A. N., a laborer, married, 43 years old, American; under observation from Jan. 25 to Feb. 6, 1895. By occupation he was an engineer. His affection began two weeks before entrance, with an initial chill, with pains over the entire body, in every joint and in the head. He had during this period suffered from hourly vomiting, and frequent diarrhea. The bowels had been usually constipated. Hiccough had troubled him excessively. His wife stated that the patient's illness began suddenly with involuntary evacuations from the bladder and rectum, accompanied by an enormous appetite and thirst. His left arm had been limp and painful for some time past. The lower extremities, together with the other parts, have grown emaciated till some six days since, when considerable anasarca about the legs and ankles developed. He had always lived in